Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.73
+0.09 (1.60%)
At close: Feb 27, 2026, 4:00 PM EST
5.58
-0.15 (-2.62%)
After-hours: Feb 27, 2026, 4:37 PM EST
Bicycle Therapeutics Employees
Bicycle Therapeutics had 305 employees as of December 31, 2024. The number of employees increased by 21 or 7.39% compared to the previous year.
Employees
305
Change (1Y)
21
Growth (1Y)
7.39%
Revenue / Employee
$92,915
Profits / Employee
-$821,836
Market Cap
397.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 834 |
| Absci | 157 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 104 |
| Armata Pharmaceuticals | 60 |
| PureTech Health | 56 |
| Candel Therapeutics | 38 |
| Anavex Life Sciences | 34 |
BCYC News
- 25 days ago - Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline - Business Wire
- 6 weeks ago - Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 - Business Wire
- 2 months ago - Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline - Business Wire
- 3 months ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire
- 4 months ago - Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results - Business Wire
- 4 months ago - Bicycle Therapeutics: Looking For Their Niche, Addressing Cash Burn - Seeking Alpha
- 6 months ago - Bicycle Therapeutics Plc (BCYC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 months ago - Bicycle Therapeutics Strengthens Board of Directors with New Appointments - Business Wire